Considering Denmark's Model for U.S. Vaccine Policy: Experts Discuss Disparities

Denmark, a small north European nation with a population comparable to that of Wisconsin, has been spotlighted as a potential blueprint for U.S. childhood vaccination strategies.

Health Secretary Robert F. Kennedy Jr., known for his critical stance on vaccinations, believes American children might be receiving unnecessary vaccinations.

In a directive earlier this month, President Trump tasked Kennedy and the interim director of the CDC with aligning U.S. practices with international norms, expressly referencing Denmark. This adjustment could mean fewer immunizations.

Critics argue that directly importing another country's vaccine framework is impractical due to distinct demographics and health considerations in the U.S.

"Our population's unique health profile makes a direct policy transplant like trying to fit a square peg in a round hole," comments an associate director at KFF.

Denmark's approach involves ten routine childhood vaccines, while the U.S. has, until recently, required immunization against 17 diseases—recently excluding hepatitis B for newborns.

Contrasting Populations and Health Systems

Unlike the diverse and economically varied U.S. population, Denmark has a comparatively uniform demographic and an integrated national health registry tracking individuals from birth.

This system efficiently manages disease outbreaks and care coordination. With parents receiving extensive parental leave and universal healthcare, Danish children have reduced disease exposure.

In contrast, the U.S. faces fragmented health coverage, with significant portions of the population uninsured or underinsured.

These differences necessitate a more comprehensive immunization schedule to mitigate health risks exacerbated by higher rates of conditions like asthma and obesity in American children.

Understanding the Risks of Policy Change

Perspectives on tailoring the U.S. vaccine schedule to match Denmark's are contentious. Adopting a minimalist approach could reintroduce preventable diseases, jeopardizing child health.

Despite misconceptions, Europe's diverse schedules reflect tailored public health strategies, not doubts about vaccine safety or efficacy.

Comparative analysis reveals the U.S.'s vaccine schedule aligns with many Western European countries, with Denmark being more restrictive.

Legal and Administrative Challenges

Legal complexities surround potential changes to U.S. vaccine policy announced without broad governmental and scientific consensus processes.

Kennedy's authority in vaccine policy, although extensive, is limited by procedural norms. Bypassing established advisory procedures might incite legal opposition.